Gero

Gero is a physics-enabled biotechnology company focused on developing therapeutics to slow down human aging and combat age-related diseases. Their approach is based on utilizing Large Health Models (LHMs) trained on real-world human data. Unlike traditional drug discovery methods, Gero's AI models are rooted in the physics of complex dynamic systems, making them fully interpretable. This enables them to identify novel targets for drugs and predict their potential effectiveness, ultimately accelerating the drug discovery process and targeting the root cause of aging.

Gero has a strong research foundation, collaborating with leading institutions like Harvard Medical School, MIT, and the University of Edinburgh. They are also actively seeking partnerships with pharmaceutical companies interested in novel drugs targeting age-related diseases. Their work has been featured in publications such as Science and Fortune, highlighting their innovative approach and commitment to extending human healthspan.

Gero.ai, a company dedicated to hacking complex diseases and aging, values collaboration and a fast-growing team of pioneers. While the company website doesn't explicitly mention job flexibility, its emphasis on a collaborative environment and attracting the best minds suggests a degree of flexibility. The "Dreamjob@gero.ai" contact for job opportunities hints at a company open to dialogue and accommodating the needs of talented individuals.

Gero is a physics-enabled biotechnology company with the mission to slow down human aging itself. They are focused on creating therapeutics against chronic diseases by leveraging AI for drug discovery and digital biomarkers, ultimately aiming to understand, measure, and control the aging process. Their approach involves building Large Health Models (LHMs) based on real-world human data, which can predict future health outcomes and reveal new treatments for chronic age-related diseases.

Gero fosters a collaborative and innovative culture, valuing contributions from scientists and experts across diverse fields. Their mission of slowing down aging and curing chronic diseases drives a sense of purpose and urgency, attracting like-minded pioneers to join their fast-growing team. The company embraces cutting-edge science, encouraging open communication, and fostering an environment where individuals can contribute their unique perspectives to solve some of humanity's most critical challenges.

Gero's approach to diversity, equity, and inclusion is not explicitly stated on their website. However, their commitment to building a diverse and inclusive team is implied by their focus on attracting "great people" to join a "fast-growing team of like-minded pioneers" and their mention of a research collaboration with the University of Edinburgh, a leading institution for diversity and inclusion in higher education.